Clinical Trials Browser

Phase 2 × Terminated × tisagenlecleucel × Clear all

NCT04161118 2023-05-06

TIGER-CTL019

Phase 2 Terminated

Lymphoma, Non-Hodgkin

NCT04225676 2023-01-30

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2 Terminated

5 enrolled 8 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma